Reply letter to “COVID-19 and Recurrent Status Epilepticus"
Keywords:
status epilepticus, SARS-CoV-2 infection, neuroinflammationReferences
Pauletto G., Nilo A., Deana C., Verriello L., Del Negro I., Lettieri C., Vetrugno L., Valente M., Gigli G.L. Recurrent Status Epilepticus and SARS-CoV-2 infection: the perfect storm. Acta Biomedica 2021; Vol 92, N.5: e2021208
C. Deana, L. Verriello, G. Pauletto, F. Corradi, F. Forfori, G. Cammarota, E. Bigani, L. Vetrugno, T. Bove. Insight into neurological dysfunction in critically ill COVID-19 patients. Trends in Anaesthesia and Critical Care, 2020.
A. Vezzani, R. Dingledine and A. O. Rossetti. Immunity and inflammation in Status Epilepticus and its sequelae: possibility for therapeutic application. Expert Rev Neurother 2015; 15(9): 1081- 1092. doi: 10.1586/14737175.2015.1079130
M. Belluzzo, A. Nilo, M. Valente, G. L. Gigli. New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci. 2021 Aug 16: 1-6. doi: 10.1007/s10072-021-05536-0
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Giada Pauletto, Annacarmen Nilo, Cristian Deana, Lorenzo Verriello, Ilaria Del Negro, Christian Lettieri, Luigi Vetrugno, Mariarosaria Valente, Gian Luigi Gigli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.